PREVENT HIV BY


PRESCRIBING PrEP


Learn More

PrEP clinical guidelines


The 2021 ASHM PrEP Guidelines are now published online. These guidelines have been reviewed and updated by the PrEP guidelines panel and reviewed by the PrEP guidelines reviewing committee.The recommendations in these guidelines are designed to:

Support clinicians in prescribing PrEP using forms of coformulated tenofovir and emtricitabine that have been registered in Australia by the Therapeutic Goods Administration and other bioequivalent generic drugs that are available in Australia through self-importation, private prescription or Australian PrEP clinical trials.

Quick steps
to prescribe PrEP